Please wait...
About This Project
Oxidized forms of the peptide beta-amyloid (Aβ) are considered to be toxic to the brain, leading to the development of Alzheimer's disease (AD). Based on our preliminary data, we hypothesize that an immunization of an AD-model mice with a recombinant protein enriched with the oxidized amino acid methionine sulfoxide will cause the removal of toxic Aβ from brain. Consequently, this treatment is expected to inhibit the development of AD and alleviate cognitive impairment.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Can perfluorocarbon liquids remove benzo(a)pyrene, a model carcinogen from cells?
Lung cancer is the single largest cause of cancer mortality, accounting for about 19% of all cancer deaths...
A Modification to Homeopathic Drug Carcinosin
Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...
Modeling Zika virus transmission from mother to child using uterine mini-organs
As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...